NeOnc CEO buys more stock after positive NEO100 Phase 2a dataSep 17Clinical readoutNeonc Technologies, Inc.perillyl alcohol
NeOnc reports Phase 2a NEO100-01 met primary endpoint in recurrent IDH1 mutant gliomaAug 13PeopleNeonc Technologies, Inc.perillyl alcohol
NeOnc reports positive Phase 2a data for NEO100 in recurrent IDH1-mutant gliomaAug 12Regulatory decisionNeonc Technologies, Inc.perillyl alcohol
NeOnc confirms August 12 topline readout for Phase 2a NEO100 glioma studyAug 10Clinical readoutNEO212Neonc Technologies, Inc.
Sign inSign in